Caffeine does affect several of women’s hormones, but the direction, size, and practical meaning of those effects depend on factors that rarely make it into casual advice. Estrogen, progesterone, cortisol, and a key carrier protein called SHBG all shift measurably in response to regular caffeine intake, and the shifts can differ by a woman’s race, her life stage, and whether she takes oral contraceptives or hormone therapy. The picture is more complex than a simple “caffeine is bad for your hormones” or “caffeine is fine.”
How Caffeine Shifts Estrogen Levels
The most striking finding in the research on caffeine and estrogen is that the effect runs in opposite directions depending on race. In a well-designed prospective study of healthy premenopausal women, white women who consumed roughly two or more cups of coffee a day (200 mg or more of caffeine) had lower free and total estradiol compared with lighter caffeine users. Among Black and Asian women in the same study, the same caffeine threshold was associated with higher estradiol levels instead.
The researchers controlled for age, body composition, stress, exercise, alcohol, and other hormone concentrations, and the racial divergence held. The reasons are not fully understood but likely involve genetic differences in how caffeine is metabolized by liver enzymes, which then feed back on estrogen clearance pathways.
A separate study looking at both premenopausal and postmenopausal women found that caffeine intake was tied to lower luteal-phase estradiol in premenopausal women specifically, meaning the second half of the menstrual cycle showed the clearest dip.
What does this mean in practice? For most women, the estrogen shifts from moderate caffeine are small enough that they fall within normal hormonal variation. But the racial differences matter if you are evaluating your own hormone labs and wondering whether your morning coffee plays a role. A white woman drinking three cups a day could be nudging her estradiol down; an Asian woman drinking the same amount could be pushing hers up.
Progesterone and the Luteal Phase
Progesterone gets less attention than estrogen in popular health content, but it is central to cycle regularity and early pregnancy support. The same study that tracked luteal estradiol found a positive association between caffeine intake and luteal progesterone in premenopausal women, though the link was specific to total caffeine rather than coffee alone.
Animal research points in the opposite direction, however. A study in female rats found that caffeine treatment reduced circulating progesterone, and the reduction persisted even after the caffeine was withdrawn, suggesting a lasting effect on the steroid-producing machinery of the ovaries.
The discrepancy between human observational data and animal experimental data is not unusual. Rats metabolize caffeine differently and were given doses that, adjusted for body weight, exceed what most people consume. The human data suggesting a slight progesterone increase at moderate intake is probably more relevant to your daily coffee habit, but the animal findings keep alive the possibility that very high or prolonged caffeine exposure could eventually suppress progesterone through a different mechanism.
Cortisol and the Stress Response
Caffeine reliably raises cortisol, the hormone most associated with the body’s stress response. In people who have abstained from caffeine for several days, even a single dose triggers a robust cortisol spike throughout the day.
Habitual use blunts but does not eliminate this effect. After five days of consuming either 300 or 600 mg of caffeine daily, the cortisol spike from a morning dose largely disappeared, but an afternoon dose still pushed cortisol back up.
The sex-specific angle is interesting. In a controlled crossover study where men and women received caffeine alongside mental stress tasks and exercise, women had a smaller cortisol response to mental stress than men did. Caffeine amplified the cortisol response to stress in both sexes equally. But after exercise followed by a meal, women showed a larger cortisol response than men, and caffeine magnified that gap further. The researchers speculated that caffeine may raise cortisol through central nervous system stimulation in men but interact more with peripheral metabolic pathways in women.
From a practical standpoint, the cortisol boost from caffeine is temporary and, in habitual drinkers, partially adapted to. But if you are already dealing with chronic stress or a condition sensitive to cortisol (like certain thyroid or adrenal issues), stacking caffeine on top of other stressors could keep cortisol elevated for longer than you’d expect.
SHBG and How It Reshapes Hormone Availability
Sex hormone-binding globulin, or SHBG, is a carrier protein in the blood that binds to estrogen and testosterone, effectively reducing the amount of those hormones that is free and active. Higher SHBG means less free hormone available to tissues, even if the total hormone level looks normal on a lab report.
In postmenopausal women, drinking four or more cups of caffeinated coffee per day was associated with SHBG levels about 15 percent higher than in non-drinkers. Decaffeinated coffee and tea did not show this association, pointing to caffeine itself as the active ingredient.
This SHBG finding has wider implications. Higher SHBG in postmenopausal women has been linked to a lower risk of type 2 diabetes, in part because SHBG also influences insulin sensitivity. So the caffeine-driven SHBG increase may help explain some of the well-documented association between coffee drinking and reduced diabetes risk in women.
A randomized controlled trial, however, muddied the waters somewhat. When researchers actually assigned people to drink caffeinated or decaffeinated coffee for eight weeks, they found no significant difference in SHBG between groups by the end of the study. There was a borderline increase in SHBG at the four-week mark in women drinking decaf, which contradicts the observational findings that pointed to caffeine specifically. The discrepancy may come down to other compounds in coffee interacting with SHBG in ways that are hard to tease apart in observational studies, or simply to the small size of the trial.
Fertility and Time to Pregnancy
Whether caffeine meaningfully delays conception is one of the most common concerns for women planning a pregnancy. The evidence is genuinely mixed. A Danish study following couples planning their first pregnancy found that nonsmoking women consuming 300 to 700 mg of caffeine daily had a slightly reduced fecundability ratio compared with lighter users, and those above 700 mg had a further reduction, though the confidence intervals were wide enough that neither result was statistically definitive.
A larger North American study found essentially no relationship between caffeine intake and time to pregnancy, even at 300 mg per day or more.
The takeaway from the fertility literature is that moderate caffeine intake, roughly two to three cups of coffee daily, does not appear to meaningfully reduce fertility for most women. Very high intake might carry a small risk, but the evidence is too imprecise to draw a firm line. Most fertility guidelines suggest staying under 200 to 300 mg daily as a precaution, which aligns with what the data can actually support.
PMS and the Caffeine Myth
It is common advice to cut caffeine if you suffer from premenstrual syndrome. A large prospective study tested this directly by comparing women across the full range of caffeine intake, from about 18 mg per day up to more than 540 mg per day, and tracking PMS development over years of follow-up. Caffeine intake was not associated with PMS risk. Even high coffee consumption showed no connection to specific symptoms like breast tenderness. The researchers concluded that current recommendations for women to reduce caffeine to prevent PMS may not be well-supported.
A systematic review and meta-analysis examining factors linked to menstrual symptom severity also found no significant odds ratios for caffeine in pooled analyses, despite noting a plausible biological mechanism: caffeine can increase uterine contractions, which could theoretically contribute to cramping. But the theoretical mechanism did not translate into a detectable real-world effect across studies.
This does not mean that you, personally, won’t feel worse after coffee during your period. Individual sensitivity is real, and some women do notice that caffeine worsens cramps or anxiety premenstrually. But on a population level, caffeine does not appear to cause or worsen PMS, and blanket advice to avoid it for cycle-related symptoms does not hold up.
Oral Contraceptives Slow Caffeine Breakdown
Here the hormonal arrow points the other direction: instead of caffeine affecting your hormones, your hormones affect caffeine. Women on combination oral contraceptives metabolize caffeine substantially more slowly. One study found that the half-life of caffeine was about 10.7 hours in women taking oral contraceptives, compared with roughly 6.2 hours in women who were not. That means the same cup of coffee sticks around in your system almost twice as long.
A second study confirmed the pattern, reporting a half-life of about 7.9 hours versus 5.4 hours in controls, with a marked decrease in the liver enzyme activity responsible for clearing caffeine.
The practical consequence is real: if you start or stop hormonal birth control, your sensitivity to caffeine can shift noticeably. A woman who tolerates three cups of coffee just fine off the pill may find the same amount leaves her jittery, sleepless, or anxious once she starts it, simply because the caffeine is hanging around longer. Adjusting your caffeine intake when changing contraceptive methods is one of those practical details that rarely makes it into a prescribing conversation but can meaningfully improve how you feel.
Menopause, Hot Flashes, and Hormone Therapy
For women going through menopause, caffeine’s relationship to vasomotor symptoms (hot flashes and night sweats) has been a point of debate. A study of midlife women found that caffeine users reported higher vasomotor symptom scores than non-users, and the association held after adjusting for menopause stage and smoking.
The effect is modest but consistent enough that women struggling with frequent hot flashes may find it worth experimenting with cutting back on caffeine to see if symptoms improve. Caffeine’s vasoconstrictive and then vasodilatory rebound action offers a plausible mechanism: anything that rapidly changes blood vessel tone can amplify the vascular instability that underlies hot flashes.
On the medication side, postmenopausal women using estrogen replacement therapy face the same caffeine-metabolism slowdown as women on oral contraceptives. A study of twelve postmenopausal women on estradiol found that their caffeine metabolism dropped by about 29 percent after eight weeks of therapy.
The implication mirrors the oral contraceptive situation: if you start hormone replacement therapy, your usual coffee intake may begin to feel like too much. The same dose of caffeine lingers longer in your bloodstream because the exogenous estrogen inhibits the liver enzyme that clears it.
Thyroid Hormones
Caffeine’s relationship with the thyroid adds another layer. An analysis of national health survey data found that low caffeine intake was positively associated with TSH (thyroid-stimulating hormone), while moderate caffeine intake showed a negative association with TSH.
This is a nonlinear pattern: very light caffeine users had slightly higher TSH than non-users, but moderate users had lower TSH, suggesting a dose-dependent curve rather than a straight line. TSH is the signal the pituitary gland sends to the thyroid, so changes in TSH can reflect changes in thyroid output. What this means clinically is still unclear, and there is a separate practical concern. Caffeine can interfere with the absorption of levothyroxine, the standard medication for hypothyroidism. Women on thyroid medication are generally advised to wait at least 30 to 60 minutes after taking their pill before having coffee, to avoid blunting the drug’s absorption.
Fibrocystic Breast Changes
The connection between caffeine and fibrocystic breast disease (lumpy, painful breasts that are common and benign but sometimes alarming) has been discussed since the 1980s. A hospital-based case-control study of more than 1,600 women in Connecticut found that women consuming 31 to 250 mg of caffeine daily had about a 1.5-fold increase in the odds of fibrocystic disease, and those consuming over 500 mg daily had a 2.3-fold increase. The association was strongest for specific tissue changes that have been linked to elevated breast cancer risk, such as atypical lobular hyperplasia and sclerosing adenosis.
Another study from the same era found elevated relative risks for dysplastic breast lesions among women drinking one to two cups or three or more cups of coffee daily compared with non-drinkers.
These studies are decades old, and their case-control design makes them vulnerable to biases that prospective research handles better. More recent evidence has been less consistent, and many clinicians no longer recommend eliminating caffeine for benign breast changes. Still, if you have fibrocystic breasts and they bother you, cutting caffeine for a month or two is a low-cost experiment that some women report helps.
Endometriosis
The data on caffeine and endometriosis pull in two different directions depending on the method used to study them. A systematic review and meta-analysis of observational studies found that high caffeine intake was associated with about a 30 percent increased risk of endometriosis. Moderate intake did not quite reach statistical significance.
However, a Mendelian randomization study, which uses genetic variants as stand-ins for caffeine exposure to get around some of the biases of observational data, found the opposite: genetically predicted higher circulating caffeine was associated with a lower probability of endometriosis.
These contradictory findings are a good reminder that observational associations can be confounded. Women with endometriosis may drink more coffee to cope with fatigue and pain, inflating the apparent association between caffeine and the disease. The genetic approach, while not perfect, suggests that caffeine itself might not be a cause. This is an area where the science has not settled, and it would be premature to advise women with endometriosis to eliminate caffeine based on current evidence.
Parathyroid Hormone and Bone Health
Caffeine also reaches the parathyroid glands, which regulate calcium balance. In laboratory experiments on human parathyroid cells, caffeine at concentrations that are physiologically achievable from normal coffee consumption suppressed both parathyroid hormone (PTH) secretion and PTH gene expression. The mechanism involved changes in signaling molecules inside the parathyroid cells rather than a direct effect on calcium levels.
PTH tells the body to pull calcium from bones when blood calcium dips. In theory, lower PTH from caffeine could mean less bone resorption, which sounds like a good thing. But the relationship between caffeine and bone density in real life is complicated by the fact that caffeine also slightly increases urinary calcium loss. For women with adequate calcium and vitamin D intake, moderate coffee consumption does not appear to threaten bone health. For women who are already calcium-deficient or at high risk for osteoporosis, the combined effects may be worth monitoring more carefully.
Coffee Versus Caffeine Versus Decaf
Throughout the research, some effects track with total caffeine from any source, while others seem specific to coffee. The SHBG increase in postmenopausal women, for instance, was linked to caffeinated coffee but not to decaf or tea. The luteal estradiol decrease in premenopausal women tracked with both caffeine broadly and coffee specifically, but the progesterone association appeared only with total caffeine, not coffee alone.
Coffee contains hundreds of bioactive compounds beyond caffeine, including chlorogenic acids, diterpenes, and polyphenols, each of which can independently affect hormonal pathways. This makes it hard to pin every observed effect squarely on the caffeine molecule. When a study says “coffee intake was associated with X,” it may be caffeine doing the work, or it may be one of coffee’s other compounds, or a combination. Decaf coffee removes most but not all caffeine and retains most of the other bioactives, which is why decaf sometimes shows effects that pure caffeine does not, and vice versa. If you are trying to isolate whether caffeine specifically is driving a hormonal change you have noticed, switching to decaf for a few weeks is a more informative experiment than switching to caffeinated tea, because it controls for more of the non-caffeine variables in coffee.